What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-based therapy for Deafness: A therapeutic mix encompassing Safranal, Cholecalciferol and DIM (SCAD) increases the expression of ATG5 (Autophagy-related 5), prevents…
read moreWhat we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Molecular therapy for Deafness: A therapeutic mix encompassing 1,4-Naphthoquinone/Para-Naphthoquinone, Cholecalciferol, Ajoene and DIM (1,4 PNCAD) increases the expression of ATG5…
read moreWhat we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-based therapy for Deafness: A therapeutic mix encompassing 3-O-laurylglyceryl ascorbate (VC-3LG), Cholecalciferol, Ajoene and DIM (VC-3LGCAD) increases the expression of…
read moreWhat we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Molecular therapy for Deafness: A therapeutic mix encompassing Clomipramine, Cholecalciferol, Ajoene and DIM (CCAD) increases the expression of ATG5 (Autophagy-related 5),…
read moreWhat we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-based therapy for Deafness: a therapeutic mix encompassing Dihydroquercetin (DHQ), Cholecalciferol, Ajoene and DIM (DHQCAD) increases the expression of ATG5…
read moreWhat we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-based therapy for Deafness: A therapeutic mix encompassing Fenofibrate, Cholecalciferol, and DIM (FECAD) increases the expression of ATG5 (Autophagy-related…
read more





